Search
Displaying results 101 - 108 of 108 in total
Dostarlimab
go.drugbank.com/drugs/DB15627ApprovedInvestigational[A234379] Agents acting on the PD-1 pathway, such as [nivolumab] and [pembrolizumab], facilitate endogenous immune-mediated anti-tumor activity and may therefore be used to treat a wide variety of cancers
Metastatic Cervical Cancer
go.drugbank.com/conditions/DBCOND0036674Drugs: Bevacizumab · Cemiplimab · Irinotecan · Pembrolizumab · Pemetrexed · Tisotumab vedotin +1 moreHepatocellular Carcinoma
go.drugbank.com/conditions/DBCOND0030090Drugs: Cabozantinib · Capecitabine · Hyaluronidase (human recombinant) · Ipilimumab · Nivolumab · Pembrolizumab +2 moreAdvanced Renal Cell Carcinoma
go.drugbank.com/conditions/DBCOND0032596Drugs: Avelumab · Axitinib · Belzutifan · Cabozantinib · Hyaluronidase (human recombinant) · Lenvatinib +6 moreUnresectable Melanoma
go.drugbank.com/conditions/DBCOND0047213Drugs: Atezolizumab · Binimetinib · Cobimetinib · Dabrafenib · Encorafenib · Hyaluronidase (human recombinant) +7 moreMetastatic Melanoma
go.drugbank.com/conditions/DBCOND0030058Metastatic Non-Small Cell Lung Cancer
go.drugbank.com/conditions/DBCOND0043377Pemetrexed Action Pathway
smpdb.ca/view/SMP0126261Drug actionThis drug is used to treat cancer specifically that of lung cancer or mesothelioma can be used in combination with pembrolizumab or cisplatin.